| NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs V Béziat, LL Liu, JA Malmberg, MA Ivarsson, E Sohlberg, AT Björklund, ... Blood, The Journal of the American Society of Hematology 121 (14), 2678-2688, 2013 | 533 | 2013 |
| Implication of γδ T cells in the human immune response to cytomegalovirus J Déchanet, P Merville, A Lim, C Retière, V Pitard, X Lafarge, S Michelson, ... The Journal of clinical investigation 103 (10), 1437-1449, 1999 | 394 | 1999 |
| Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor H Aldemir, V Prod’homme, MJ Dumaurier, C Retiere, G Poupon, ... The Journal of Immunology 175 (12), 7791-7795, 2005 | 342 | 2005 |
| Cell‐surface expression and immune receptor recognition of HLA–B27 homodimers S Kollnberger, L Bird, MY Sun, C Retiere, VM Braud, A McMichael, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 304 | 2002 |
| UL40-mediated NK evasion during productive infection with human cytomegalovirus ECY Wang, B McSharry, C Retiere, P Tomasec, S Williams, ... Proceedings of the National Academy of Sciences 99 (11), 7570-7575, 2002 | 216 | 2002 |
| Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T … E Scotet, MA Peyrat, X Saulquin, C Retiere, C Couedel, F Davodeau, ... European journal of immunology 29 (3), 973-985, 1999 | 159 | 1999 |
| Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the … C Retière, V Prod'homme, BM Imbert-Marcille, M Bonneville, H Vié, ... Journal of Virology 74 (9), 3948-3952, 2000 | 125 | 2000 |
| Large spectrum of HLA-C recognition by killer Ig–like receptor (KIR) 2DL2 and KIR2DL3 and restricted C1 specificity of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK … G David, Z Djaoud, C Willem, N Legrand, P Rettman, K Gagne, A Cesbron, ... The Journal of Immunology 191 (9), 4778-4788, 2013 | 110 | 2013 |
| Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral … C Retière, C Willem, T Guillaume, H Vié, L Gautreau-Rolland, E Scotet, ... Oncotarget 9 (14), 11451, 2018 | 61 | 2018 |
| Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells Z Djaoud, G David, C Bressollette, C Willem, P Rettman, K Gagne, ... The Journal of Immunology 191 (5), 2708-2716, 2013 | 60 | 2013 |
| Discrimination between the main activating and inhibitory killer cell immunoglobulin‐like receptor positive natural killer cell subsets using newly characterized monoclonal … G David, M Morvan, K Gagne, N Kerdudou, C Willem, A Devys, ... Immunology 128 (2), 172-184, 2009 | 59 | 2009 |
| Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK‐cell functions M Morvan, G David, V Sébille, A Perrin, K Gagne, C Willem, N Kerdudou, ... European journal of immunology 38 (12), 3474-3486, 2008 | 56 | 2008 |
| Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK … M Morvan, C Willem, K Gagne, N Kerdudou, G David, V Sébille, G Folléa, ... The Journal of Immunology 182 (11), 6727-6735, 2009 | 49 | 2009 |
| Impact of KIR/HLA incompatibilities on NK cell reconstitution and clinical outcome after T cell–replete haploidentical hematopoietic stem cell transplantation with … C Willem, DR Makanga, T Guillaume, B Maniangou, N Legrand, K Gagne, ... The Journal of Immunology 202 (7), 2141-2152, 2019 | 45 | 2019 |
| Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after trauma-hemorrhage A Roquilly, A Broquet, C Jacqueline, D Masson, JP Segain, C Braudeau, ... Critical Care Medicine 42 (12), e752-e761, 2014 | 44 | 2014 |
| The T cell surface—how well do we know it? EJ Evans, L Hene, LM Sparks, T Dong, C Retiere, JA Fennelly, ... Immunity 19 (2), 213-223, 2003 | 42 | 2003 |
| High-resolution genetic and phenotypic analysis of KIR2DL1 alleles and their association with pre-eclampsia O Huhn, O Chazara, MA Ivarsson, C Retiere, TC Venkatesan, PJ Norman, ... The Journal of Immunology 201 (9), 2593-2601, 2018 | 41 | 2018 |
| Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK‐cell repertoire in the French population K Gagne, C Willem, N Legrand, Z Djaoud, G David, P Rettman, ... European Journal of Immunology 43 (4), 1085-1098, 2013 | 38 | 2013 |
| Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients. CM Dominguez-Valentin M, Gras Navarro A, Rahman AM, Kumar S, Retière C ... Cancer Research 76 (18), 5326-36, 2016 | 33 | 2016 |
| NKG2D controls natural reactivity of Vγ9Vδ2 T lymphocytes against mesenchymal glioblastoma cells C Chauvin, N Joalland, J Perroteau, U Jarry, L Lafrance, C Willem, ... Clinical Cancer Research 25 (23), 7218-7228, 2019 | 32 | 2019 |
